Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Neuronetics12,000 enrolled

Overview

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

this is a retrospective data analysis study that will utilize the already collected data as clinical care and will help understand the utilization and efficacy of various treatment options available for various mental heath conditions.

Study Type

OBSERVATIONAL

Enrollment

12,000

Conditions

Depression OCD Anxiety Depression

Interventions

Patients treated with NeuroStar TMSDEVICE

non-invasive brain stimulation device

Patients treated with EsketamineDRUG

nasal spray for treating depression

Eligibility

Sex: ALLMin age: 5 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date in 2011 or later. Exclusion Criteria: • Incomplete information on treatment parameters

Locations (1)

Neuronetics

Malvern, Pennsylvania, United States

RECRUITING

Outcomes

Primary Outcomes

change in clinical outcome scores from baseline to post treatment

real-world efficacy of NeuroStar TMS as compared to Esketamine in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9

Time frame: 8 weeks

Central Contacts

Neha Goyal

CONTACT

7635281599 neha.goyal@neurostar.com

Eleanor Cole, PhD

CONTACT

415-724-7960 Eleanor.cole@neurostar.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.